Genzyme Recalls Murky Batches Of Transplant Drug
The company recalled the batches after federal regulators noticed vials of the drug appeared cloudier than normal during a routine quality control inspection, a spokeswoman for Genzyme said Friday.
The three recalled lots of the drug, manufactured in 2007, do not pose a health risk to patients and the company does not expect to...
Already a subscriber? Click here to login